cyclosporine has been researched along with Bone Diseases, Metabolic in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (53.49) | 18.2507 |
2000's | 16 (37.21) | 29.6817 |
2010's | 4 (9.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrahamsen, B; Andersen, LS; Ellingsen, T; Hansen, I; Hansen, MS; Hetland, ML; Hyldstrup, L; Hørslev-Petersen, K; Jensen, TW; Junker, P; Jurik, AG; Langdahl, B; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Petersen, K; Svendsen, AJ; Tarp, U; Vestergaard, A; Zerahn, B; Østergaard, M | 1 |
Chang, DM; Chen, WS; Chou, CT; Lai, CC; Tsai, CY; Tsao, YP; Wu, TH | 1 |
Ahmadpoor, P; Ghafari, A; Makhdoomi, K; Rahimi, E; Reisi, S; Sepehrvand, N | 1 |
Chen, RY; Chiang, CY; Chih, YK; Fu, E; Fu, MM; Gau, CH; Hsieh, YD; Nieh, S | 1 |
Erben, RG; Jäger, W; Rubel, F; Schüler, C; Wlcek, K; Xu, H | 1 |
Huynh, VM; Lai, LW; Lee, CT; Lien, YH | 1 |
Drexel, H; Gouya, G; Hergan, K; Höfle, G; Holzmüller, H; Hubmann, M; Langer, P | 1 |
Beelen, DW; Schulte, CM | 1 |
Chiu, MY; Josephson, MA; Marshall, C; Schumm, LP; Sprague, SM; Thistlethwaite, JR | 1 |
Ballanti, P; Bianchi, G; Cannella, G; Marsano, L; Messa, P; Paoletti, E; Rolla, D | 1 |
Chen, YH; Chou, NK; Kuo, HL; Su, IC; Wang, SS; Yang, RS | 1 |
Armstrong, EC; Bryer, HP; Buchinsky, FJ; Epstein, S; Isserow, JA; Mann, GN; Romero, DF; Rucinski, B | 1 |
Bognar, B; Briner, VA; Kamber, V; Landmann, J; Malluche, HH; Monier-Faugere, MC; Thiel, G | 1 |
Klein, L; Lemel, MS; Shaffer, J; Wolfe, MS | 1 |
Jones, G; Sambrook, PN | 1 |
Bartucci, MR; Deal, CL; Fleming-Brooks, S; Hricik, DE; Schulak, JA; Wolpaw, T | 1 |
Epstein, S; Jee, WS; Joffe, II; Katz, IA; Ke, HZ; Li, M; Liang, XG; Romero, DF; Stein, B; Takizawa, M | 1 |
Armstrong, EC; Buchinsky, FJ; Epstein, S; Jacobs, TW; Jee, WS; Ke, HZ; Li, M; Ma, YF; Mann, GN | 1 |
Epstein, S; Liu, CC; Rucinski, B | 1 |
Epstein, S; Jacobs, T; Jee, W; Joffe, I; Katz, I; Ke, HZ; Li, M; Liang, XG; Stein, B | 1 |
Bryer, HP; Buchinsky, FJ; Epstein, S; Jee, WS; Ma, Y; Mann, GN; Romero, DF; Rucinski, B | 1 |
Hay, JE; Krom, RA; Lee, SG; Lee, YJ; Park, KM; Porayko, MK; Wiesner, RH | 1 |
Bryer, HP; Buchinsky, FJ; Chen, HK; Epstein, S; Jee, WS; Ma, YF; Mann, GN; Rucinski, B; Sass, DA | 1 |
Bowman, AR; Epstein, S; Jee, WS; Liang, H; Ma, YF; Marshall, I; Sass, DA | 1 |
Bowman, AR; Epstein, S; Liss, T; Ma, YF; Pan, Z; Popoff, SN; Rucinski, B; Sass, DA | 1 |
Bowman, AR; Dissanayake, IR; Epstein, S; Jee, WS; Liang, H; Ma, YF; Sass, DA; Yuan, Z | 1 |
Bowman, AR; Epstein, S; Jee, WS; Ma, Y; Sass, DA; Yuan, Z | 1 |
Ebeling, PR; Erbas, B; Grigg, AP; Hopper, JL; Szer, J; Thomas, DM | 1 |
Adams, JE; Crowley, V; Cueto-Manzano, AM; France, MW; Freemont, AJ; Gokal, R; Hutchison, AJ; Konel, S; Mawer, B | 1 |
Sprague, SM | 1 |
Achard, JM; Brazier, M; El Esper, I; Ezaitouni, F; Fardellone, P; Fournier, A; Hottelart, C; Ivan, C; Mazouz, H; Petit, J; Pruna, A; Westeel, FP | 1 |
Dissanayake, IR; Epstein, S; Goodman, GR; Gorodetsky, E; Jee, WS; Lu, J; Ma, YF; Sodam, BR | 1 |
Amico-Roxas, M; Caruso, A; Clementi, G; Cutuli, VM; Fiore, CE; Mangano, NG; Matera, M; Pennisi, P; Prato, A | 1 |
Depresseux, G; Devogelaer, JP; Goffin, E; van Ypersele de Strihou, C | 1 |
Awumey, EM; Epstein, S; Sampson, WH; Sodam, BR | 1 |
Bowman, AR; Dissanayake, IR; Epstein, S; Goodman, GR; Jee, WS; Ma, Y; Zhou, H | 1 |
Fournier, A; Mazouz, H; Oprisiu, R; Westeel, FP | 1 |
Bowman, AR; Bryer, HP; Dissanayake, IR; Epstein, S; Goodman, GR; Jee, WS; Ma, Y; Pun, S | 1 |
Jacobs, TW; Jee, WS; Joffe, II; Katz, IA; Ke, HZ; Lin, BY; Setterberg, R; Stein, B; Takizawa, M; Tang, LY | 1 |
Berlin, J; Epstein, S; Jacobs, T; Joffe, I; Katz, I; Liu, C; Stein, B; Takizawa, M | 1 |
Berman, BW; Splain, J | 1 |
Epstein, S | 1 |
Ayer, LM; Gundberg, CM; Hanley, DA; Minuk, GY | 1 |
2 review(s) available for cyclosporine and Bone Diseases, Metabolic
Article | Year |
---|---|
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.
Topics: Adrenal Cortex Hormones; Aluminum; Anticonvulsants; Bone Diseases, Metabolic; Calcium; Cyclosporine; Diphosphonates; Fluorides; Heparin; Hormones; Humans; Methotrexate | 1994 |
Mechanism of transplantation-associated bone loss.
Topics: Animals; Bone Diseases, Metabolic; Cyclosporine; Fractures, Bone; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation | 2000 |
7 trial(s) available for cyclosporine and Bone Diseases, Metabolic
Article | Year |
---|---|
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Topics: Adult; Aged; Alendronate; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome; Young Adult | 2014 |
Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.
Topics: Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Calcium; Cohort Studies; Cyclosporine; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Prospective Studies; Risk Factors; Steroids; Transplantation, Homologous; Vitamin D | 2004 |
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Calcitriol; Calcium; Calcium Channel Agonists; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Femur Neck; Humans; Immunosuppressive Agents; Kidney Transplantation; Lumbar Vertebrae; Pancreas Transplantation; Radius; Tacrolimus; Vitamin D | 2004 |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
Topics: Alkaline Phosphatase; Bilirubin; Bone Diseases, Metabolic; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Tacrolimus; Time Factors | 1996 |
Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
Topics: Absorptiometry, Photon; Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bone Density; Bone Diseases, Metabolic; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Osteoclasts; Postmenopause; Prednisolone; Premenopause; Sex Factors | 1999 |
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Topics: Absorptiometry, Photon; Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cyclosporine; Female; Femur Neck; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lumbar Vertebrae; Male; Middle Aged; Postoperative Complications; Prednisone; Prospective Studies; Radius; Treatment Outcome | 2000 |
Parameters of calcium metabolism during a pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis.
Topics: Bone Diseases, Metabolic; Calcifediol; Calcitriol; Calcium; Creatinine; Cyclosporine; Humans; Liver Cirrhosis, Biliary; Minerals; Osteocalcin; Parathyroid Hormone; Pilot Projects | 1991 |
34 other study(ies) available for cyclosporine and Bone Diseases, Metabolic
Article | Year |
---|---|
Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Cross-Sectional Studies; Cyclosporine; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucocorticoids; Humans; Immunosuppressive Agents; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Male; Middle Aged; Osteoporosis; Premenopause; Treatment Outcome | 2015 |
Osteoporosis and related risk factors in renal transplant recipients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Creatinine; Cyclosporine; Hip Joint; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lumbar Vertebrae; Middle Aged; Mycophenolic Acid; Osteoporosis; Prednisolone; Risk Factors; Spine; Young Adult | 2009 |
Effect of cyclosporine-A on orthodontic tooth movement in rats.
Topics: Acid Phosphatase; Alveolar Process; Animals; Biomarkers; Bone Diseases, Metabolic; Bone Remodeling; Cyclosporine; Immunosuppressive Agents; Isoenzymes; Male; Maxilla; Molar; Orthodontic Wires; Osteoclasts; Random Allocation; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Tartrate-Resistant Acid Phosphatase; Time Factors; Tooth Movement Techniques | 2011 |
Gender- and dose-related effects of cyclosporin A on hepatic and bone metabolism.
Topics: Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Cyclosporine; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Liver; Male; Models, Theoretical; Rats; Rats, Inbred F344; Sex Factors | 2012 |
Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice.
Topics: Animals; Anti-Inflammatory Agents; Bone Diseases, Metabolic; Calbindin 1; Calbindins; Calcium; Calcium Channels; Cyclosporine; Diphosphonates; Gene Expression; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Knockout; Pamidronate; S100 Calcium Binding Protein G | 2002 |
Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone.
Topics: Bone Density; Bone Diseases, Metabolic; Collagen; Cross-Sectional Studies; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Osteoporosis; Peptide Fragments; Prednisolone; Retrospective Studies | 2003 |
Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.
Topics: Adult; Aged; Biopsy; Bone and Bones; Bone Diseases; Bone Diseases, Metabolic; Cross-Sectional Studies; Cyclosporine; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoblasts; Spinal Fractures | 2006 |
Bone mineral density in long-term Chinese heart transplant recipients: a cross-sectional study.
Topics: Adult; Aged; Body Size; Bone Density; Bone Diseases, Metabolic; Cross-Sectional Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Taiwan; Time Factors | 2006 |
Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
Topics: Animals; Azathioprine; Body Weight; Bone Diseases, Metabolic; Calcitriol; Calcium; Cyclosporine; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Male; Osteocalcin; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Standards; Treatment Outcome | 1995 |
Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcitriol; Calcium; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Prednisone; Prospective Studies; Time Factors | 1995 |
Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cyclosporine; Male; Organ Size; Osteogenesis; Rats; Rats, Sprague-Dawley | 1994 |
Factors influencing vertebral bone density after renal transplantation.
Topics: Adult; Aged; Bone Density; Bone Diseases, Metabolic; Cyclosporine; Female; Humans; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postmenopause; Regression Analysis; Steroids | 1994 |
Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Topics: Animals; Blood Glucose; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Calcium; Cyclosporine; Diabetes Mellitus, Experimental; Male; Minerals; Osteocalcin; Osteogenesis; Parathyroid Hormone; Rats; Rats, Sprague-Dawley | 1994 |
Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
Topics: Animals; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Calcitriol; Calcium; Cyclosporine; Interferon-gamma; Ions; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Reference Values; Tibia | 1994 |
Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Remodeling; Calcitriol; Cyclosporine; Male; Osteocalcin; Parathyroid Hormone; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 1994 |
Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Topics: Administration, Oral; Aging; Animals; Blood Urea Nitrogen; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcitriol; Calcium; Creatinine; Cyclosporine; Disease Models, Animal; Male; Osteocalcin; Osteoporosis; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Tibia | 1994 |
T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.
Topics: Animals; Blood Glucose; Bone and Bones; Bone Diseases, Metabolic; Calcitriol; Calcium; Creatinine; Cyclosporine; Immunosuppressive Agents; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Nude; Rats, Sprague-Dawley; T-Lymphocytes; Urea | 1996 |
Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.
Topics: Animals; Blood Glucose; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cyclosporine; Humans; Insulin-Like Growth Factor I; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Tibia; Weight Gain | 1996 |
Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
Topics: Animals; Bone and Bones; Bone Diseases, Metabolic; Cyclosporine; Drug Evaluation, Preclinical; Drug Synergism; Estrogen Antagonists; Estrogens; Female; Liver; Ovariectomy; Ovary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Thiophenes; Uterus | 1996 |
The role of the T-lymphocyte in estrogen deficiency osteopenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Cyclosporine; Disease Models, Animal; Estrogens; Female; Osteocalcin; Ovariectomy; Ovary; Rats; Rats, Nude; T-Lymphocytes; Tibia; Vitamin D | 1997 |
The role of testosterone in cyclosporine-induced osteopenia.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Bone Diseases, Metabolic; Calcium; Creatinine; Cyclosporine; Drug Synergism; Humans; Immunosuppressive Agents; Male; Organ Transplantation; Osteocalcin; Osteoporosis; Rats; Rats, Sprague-Dawley; Tacrolimus; Testosterone | 1997 |
Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Topics: Administration, Oral; Alendronate; Analysis of Variance; Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Calcium; Cyclosporine; Disease Models, Animal; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Subcutaneous; Male; Osteocalcin; Osteoclasts; Parathyroid Hormone; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia | 1997 |
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cross-Sectional Studies; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Longitudinal Studies; Male; Middle Aged; Prednisolone; Risk Factors; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Immunosuppressant use without bone loss--implications for bone loss after transplantation.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Immunosuppressive Agents; Male; Organ Transplantation; Osteocalcin; Rats; Rats, Sprague-Dawley; Sirolimus; Tibia | 2001 |
Role of soy diet and L-arginine in cyclosporin-A-induced osteopenia in rats.
Topics: Animals; Arginine; Body Weight; Bone Density; Bone Diseases, Metabolic; Calcium; Cyclosporine; Diet; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Pelvic Bones; Radiography; Rats; Rats, Sprague-Dawley; Soybean Proteins; Spine | 2001 |
Bone mass evolution after renal transplantation.
Topics: Bone Diseases, Metabolic; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Steroids | 2001 |
The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
Topics: Acetamides; Administration, Oral; Animals; Blood Urea Nitrogen; Body Weight; Bone Diseases, Metabolic; Calcitriol; Calcium; Creatinine; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Immunosuppressive Agents; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Tibia | 2001 |
Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
Topics: Animals; Binding, Competitive; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Cyclosporine; Drug Interactions; Male; Organ Size; Osteocalcin; Parathyroid Hormone; Parathyroidectomy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Tibia; Vitamin D | 2001 |
Bone remodeling effect of cyclosporine protects against steroid-induced osteopenia.
Topics: Bone and Bones; Bone Diseases, Metabolic; Bone Remodeling; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Steroids | 2001 |
Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Ergocalciferols; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2001 |
Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
Topics: Administration, Oral; Animals; Bone Density; Bone Diseases, Metabolic; Calcitriol; Cyclosporine; Dinoprostone; Female; Image Processing, Computer-Assisted; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley | 1992 |
17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
Topics: Animals; Body Weight; Bone Development; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cyclosporine; Estradiol; Female; Osteocalcin; Ovariectomy; Parathyroid Hormone; Rats; Rats, Inbred Strains | 1992 |
Cyclosporin A treatment for Diamond-Blackfan anemia.
Topics: Adolescent; Bone Diseases; Bone Diseases, Metabolic; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Fanconi Anemia; Female; Fractures, Bone; Growth Disorders; Hematocrit; Humans; Male; Prednisone | 1992 |
Cyclosporin A: friend or foe?
Topics: Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Cyclosporine; Female; Humans; In Vitro Techniques; Male; Rats | 1991 |